172 related articles for article (PubMed ID: 38211889)
21. The role of anti-eosinophilic therapies in eosinophilic granulomatosis with polyangiitis: a systematic review.
Kouverianos I; Angelopoulos A; Daoussis D
Rheumatol Int; 2023 Jul; 43(7):1245-1252. PubMed ID: 37085573
[TBL] [Abstract][Full Text] [Related]
22. Benralizumab in eosinophilic granulomatosis with polyangiitis complicated by Staphylococcus aureus sepsis.
Kolios AGA; Lutterotti A; Kulcsar Z; Renner T; Rudiger A; Nilsson J
Clin Immunol; 2021 Jan; 222():108574. PubMed ID: 32805452
[TBL] [Abstract][Full Text] [Related]
23. Benralizumab for eosinophilic granulomatosis with polyangiitis.
Cottu A; Groh M; Desaintjean C; Marchand-Adam S; Guillevin L; Puechal X; Beaumesnil S; Lazaro E; Samson M; Taille C; Durel CA; Diot E; Nicolas S; Guilleminault L; Ebbo M; Cathebras P; Dupin C; Yildiz H; Belfeki N; Pugnet G; Chauvin P; Jouneau S; Lifermann F; Martellosio JP; Cottin V; Terrier B;
Ann Rheum Dis; 2023 Dec; 82(12):1580-1586. PubMed ID: 37550002
[TBL] [Abstract][Full Text] [Related]
24. A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
Quan MV; Frankel SK; Maleki-Fischbach M; Tan LD
BMC Pulm Med; 2018 Nov; 18(1):181. PubMed ID: 30497438
[TBL] [Abstract][Full Text] [Related]
25. Asthma control in eosinophilic granulomatosis with polyangiitis treated with rituximab.
Casal Moura M; Berti A; Keogh KA; Volcheck GW; Specks U; Baqir M
Clin Rheumatol; 2020 May; 39(5):1581-1590. PubMed ID: 31897956
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of prognostic factors for patients with eosinophilic granulomatosis with polyangiitis recruited at the pneumonological centre and mainly ANCA negativity: A retrospective analysis of a single cohort in Poland.
Fijolek J; Wiatr E; Bujnowski P; Piotrowska-Kownacka D; Roszkowski-Sliz K
Mod Rheumatol; 2023 Dec; 34(1):157-166. PubMed ID: 36658715
[TBL] [Abstract][Full Text] [Related]
27. A patient with eosinophilic granulomatosis with polyangiitis successfully weaned from corticosteroids through remission induction therapy with mepolizumab.
Ueno M; Miyagawa I; Kawabe A; Kusaka K; Nakayamada S; Tanaka Y
Mod Rheumatol Case Rep; 2022 Jun; 6(2):243-247. PubMed ID: 35366318
[TBL] [Abstract][Full Text] [Related]
28. Churg-Strauss syndrome.
Greco A; Rizzo MI; De Virgilio A; Gallo A; Fusconi M; Ruoppolo G; Altissimi G; De Vincentiis M
Autoimmun Rev; 2015 Apr; 14(4):341-8. PubMed ID: 25500434
[TBL] [Abstract][Full Text] [Related]
29. Mepolizumab exerts crucial effects on glucocorticoid discontinuation in patients with eosinophilic granulomatosis with polyangiitis: a retrospective study of 27 cases at a single center in Japan.
Yamane T; Hashiramoto A
Arthritis Res Ther; 2023 Jun; 25(1):110. PubMed ID: 37365612
[TBL] [Abstract][Full Text] [Related]
30. Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis.
McBrien CN; Menzies-Gow A
Drugs Today (Barc); 2018 Feb; 54(2):93-101. PubMed ID: 29637936
[TBL] [Abstract][Full Text] [Related]
31. ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics.
Piga MA; Fraticelli P; Antonicelli L; Garritani MS; Ghirelli G; Martini M; Di Vincenzo A; Danieli MG; Moroncini G; Bilò MB
Front Immunol; 2023; 14():1325299. PubMed ID: 38090592
[TBL] [Abstract][Full Text] [Related]
32. Familial Eosinophilic Granulomatosis with Polyangiitis in a Sister and Brother.
Ueki Y; Oshikata C; Asai Y; Kaneko T; Tsurikisawa N
Intern Med; 2020 Apr; 59(7):991-995. PubMed ID: 31813915
[TBL] [Abstract][Full Text] [Related]
33. [Eosinophilic granulomatosis with polyangiitis : Update on classification and management].
Hellmich B; Holle J; Moosig F
Z Rheumatol; 2022 May; 81(4):286-299. PubMed ID: 35075511
[TBL] [Abstract][Full Text] [Related]
34. Eosinophilic granulomatosis with polyangiitis: the multifaceted spectrum of clinical manifestations at different stages of the disease.
Berti A; Boukhlal S; Groh M; Cornec D
Expert Rev Clin Immunol; 2020 Jan; 16(1):51-61. PubMed ID: 31762336
[No Abstract] [Full Text] [Related]
35. Multi-targeted therapy for refractory eosinophilic granulomatosis with polyangiitis characterized by intracerebral hemorrhage and cardiomyopathy: a case-based review.
Mutoh T; Shirai T; Sato H; Fujii H; Ishii T; Harigae H
Rheumatol Int; 2022 Nov; 42(11):2069-2076. PubMed ID: 34287685
[TBL] [Abstract][Full Text] [Related]
36. Benralizumab: A novel treatment for the cutaneous features of paediatric eosinophilic granulomatosis with polyangiitis (pEGPA).
Bandla M; Howard M; McNally A; Armstrong D; Simpson I; Mar A
Australas J Dermatol; 2023 Aug; 64(3):404-407. PubMed ID: 37195732
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis.
Manka LA; Guntur VP; Denson JL; Dunn RM; Dollin YT; Strand MJ; Wechsler ME
Ann Allergy Asthma Immunol; 2021 Jun; 126(6):696-701.e1. PubMed ID: 33548468
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis.
Teixeira V; Mohammad AJ; Jones RB; Smith R; Jayne D
RMD Open; 2019; 5(1):e000905. PubMed ID: 31245051
[TBL] [Abstract][Full Text] [Related]
39. Eosinophilic granulomatosis with polyangiitis: myocardial thickening reversed by corticosteroids.
Mattsson G; Magnusson P
BMC Cardiovasc Disord; 2017 Dec; 17(1):299. PubMed ID: 29262787
[TBL] [Abstract][Full Text] [Related]
40. Long-Term Followup of a Multicenter Cohort of 101 Patients With Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss).
Durel CA; Berthiller J; Caboni S; Jayne D; Ninet J; Hot A
Arthritis Care Res (Hoboken); 2016 Mar; 68(3):374-87. PubMed ID: 26315340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
